Novamind to Conduct Phase II Psilocybin Trial for Major Depressive Disorder

Novamind to Conduct Phase II Psilocybin Trial for Major Depressive Disorder

Novamind (NM) began a Phase II trial on psilocybin for depression, which is sponsored by the non-profit Usona Institute. 

PDF of article